Social Reality has agreed to sell SRAXmd to Halyard Capital for a consideration of up to $52.5 million. SRAXmd is the healthcare and pharmaceutical digital advertising product line for Social Reality Inc, a digital marketing and consumer data management and distribution technology platform company.